Rhymetec Celebrates a Decade of Innovation, Growth and Expansion, Poised for Future Growth
Leading cloud security company celebrates 10 years of success attributing sustainable growth to its highly skilled team, strategic partnerships and expanding globally ... Read more.
Trinasolar develops world’s first 800W+ tandem module, ushering in a new era
CHANGZHOU, China, March 28, 2025 /PRNewswire/ — Trinasolar, a global leader in smart PV and energy storage solutions, has announced that it has developed the... Read more.
Reign Supreme with Regal Riches! Slotomania’s Latest Virtual Slot Game from IGT
Prepare for a royal adventure with fan-favorite IGT Regal Riches, the newest game packed with wild features and dazzling bonus rounds, arriving March 28, 2025! HERZLIYA,... Read more.
SkylineDx presents landmark findings from the largest prospective multicenter melanoma GEP trial at SSO 2025
Merlin CP-GEP test delivers high clinical utility – Study prospectively confirms precise risk stratification, optimizing SLNB referral recommendations. High clinical... Read more.
ICEYE to provide SAR Satellite Data to the Situation Center at NATO
HELSINKI and BRUSSELS, March 28, 2025 /PRNewswire/ — ICEYE, the global leader in Synthetic Aperture Radar (SAR) satellite operations for Earth Observation,... Read more.
Mediaplanet and Robert Herjavec Spotlight Strategies for a Healthier, More Productive Workforce
NEW YORK, March 28, 2025 /PRNewswire/ — Mediaplanet today announces the launch of its Employee Well-Being campaign, a timely initiative addressing the critical... Read more.
Atlantic Street Capital partners with Dynamic Campus
NEW YORK, March 28, 2025 /PRNewswire/ — Atlantic Street Capital (“ASC”), a private equity firm that invests in lower middle market companies poised... Read more.
Korea Zinc Announces AGM Results, with the Current Management Retaining Control of the Board with Overwhelming Shareholder Support
SEOUL, South Korea, March 28, 2025 /PRNewswire/ — Korea Zinc (KRX:010130) announced on March 28 that it has successfully concluded its annual general meeting... Read more.
Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
Clinical Remission: Achieved in 33% of PL8177-treated patients versus 0% on placebo after eight weeks of treatment. Clinical Response (statistically significant):... Read more.
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
DOVER, Del., March 28, 2025 /PRNewswire/ — Lomond Therapeutics Holdings, Inc. (“Lomond Therapeutics”), a clinical-stage biotechnology company dedicated... Read more.